表紙
市場調查報告書

介入神經放射學:腦動脈瘤·腦動靜脈畸形 (AVM) 栓塞系統

Interventional Neurology: Cerebral Aneurysm and Arteriovenous Malformation Embolization Systems

出版商 Datamonitor Healthcare 商品編碼 858228
出版日期 內容資訊 英文 68 Pages
商品交期: 最快1-2個工作天內
價格
介入神經放射學:腦動脈瘤·腦動靜脈畸形 (AVM) 栓塞系統 Interventional Neurology: Cerebral Aneurysm and Arteriovenous Malformation Embolization Systems
出版日期: 2018年11月08日內容資訊: 英文 68 Pages
簡介

本報告提供世界 (美國,日本,EU5個國家,其他地區)的腦動脈瘤·腦動靜脈畸形 (AVM) 栓塞系統市場相關調查分析,提供疾病概要,產品,市場預測相關的系統性資訊。

第1章 臨床概要

  • 腦內出血
  • 蜘蛛網膜下腔出血
  • 腦動脈瘤
  • 腦動靜脈畸形
  • 腦動脈瘤·腦動靜脈畸形 (AVM)的修復
  • 參考文獻

第2章 腦神經血管內栓塞產品

  • 微線圈栓塞產品
  • 液體栓塞
  • 用於寬頸動脈瘤的支架產品
  • 流動分流裝置
  • 血流隔斷·其他新興腦動脈瘤栓塞設備
  • 目前臨床試驗
  • 參考文獻

第3章 腦動脈瘤·腦動靜脈畸形 (AVM) 栓塞系統市場

  • 綜合市場預測
  • 綜合治療數量預測
  • 綜合競爭分析
  • 栓塞線圈
  • 液體栓塞
  • 支架輔助線圈用腦神經血管內支架
  • 流動轉向,血流隔斷,其他栓塞系統
  • 參考文獻

附錄:企業清單

目錄
Product Code: #MDT18018

Overview

This medical market and technology report provides a comprehensive discussion of the global market for neurointerventional cerebral aneurysm and arteriovenous malformation (AVM) embolization systems. This market, as covered by the scope of this analysis, comprises the following product segments: endovascular coils, liquid embolics, stents for stent-assisted coiling, flow diversion and flow disruption systems, and other novel and emerging embolization devices. Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries.

This report provides the following useful information:

  • in depth market and competitive analysis
  • clinical overview of neurointerventional embolization procedures for intracranial applications
  • incidence and prevalence data for cerebral aneurysms and AVMs
  • product portfolios offered by leading manufacturers
  • top-selling devices, as well as emerging products

TABLE OF CONTENTS

Executive Summary

  • i. Embolization systems
    • a. Embolic coiling
    • b. Liquid embolics
    • c. Neuroendovascular stents for stent-assisted coiling
    • d. Flow diversion, flow disruption, and other embolic systems
  • ii. Combined market forecast
    • a. Market leaders
  • iii. Methodology
  • Exhibit ES-1: Embolization systems for treatment of cerebral aneurysms and AVMs, combined market forecast ($m), by region, 2017-22

1. Clinical Overview

  • 1.1. Intracerebral hemorrhage
  • 1.2. Subarachnoid hemorrhage
  • 1.3. Cerebral aneurysm
  • 1.4. Arteriovenous malformations
  • 1.5. Repair of cerebral aneurysms and AVMs
    • 1.5.1. Surgical clipping
    • 1.5.2. Endovascular embolization
    • 1.5.3. Stent-assisted coiling
    • 1.5.4. Flow diversion
    • 1.5.5. ARUBA clinical trial
  • 1.6. Bibliography
  • Exhibit 1-1: Clinical features and characteristics of hemorrhagic stroke
  • Exhibit 1-2: Global incidence and prevalence, by gender, hemorrhagic stroke, absolute number, in millions, 1990. and 2013
  • Exhibit 1-3: Illustration of an embolic coil procedure for cerebral aneurysms
  • Exhibit 1-4: Illustration of an endovascular embolization procedure for arteriovenous malformations

2. Neuroendovascular Embolization Products

  • 2.1. Microcoil embolization products
  • 2.2. Liquid embolics
  • 2.3. Stent products for wide-neck aneurysms
  • 2.4. Flow diversion devices
  • 2.5. Flow disruption and other novel/emerging aneurysm embolization devices
  • 2.6. Current clinical trials
  • 2.7. Bibliography
  • Exhibit 2-1: Advantages and disadvantages of cerebral aneurysm clipping versus coiling procedures
  • Exhibit 2-2: Selected neuroendovascular aneurysm microcoils, 2018
  • Exhibit 2-3: Selected liquid embolics, 2018
  • Exhibit 2-4: Selected neuroendovascular stents for the treatment of wide-neck aneurysms
  • Exhibit 2-5: Selected flow diversion devices, 2018
  • Exhibit 2-6: Selected flow disruption and other novel embolic systems, 2018
  • Exhibit 2-7: Selected clinical trials of neuroendovascular embolic systems for aneurysms and AVMs, 2018

3. Market for Cerebral Aneurysm and Arteriovenous Malformation Embolization Systems

  • 3.1. Combined market forecast
  • 3.2. Combined procedure volumes forecast
  • 3.3. Combined competitive analysis
  • 3.4. Embolic coiling
    • 3.4.1. Procedure volumes forecast
    • 3.4.2. Market forecast
    • 3.4.3. Competitive analysis
  • 3.5. Liquid embolics
    • 3.5.1. Procedure volumes forecast
    • 3.5.2. Market forecast
    • 3.5.3. Competitive analysis
  • 3.6. Neuroendovascular stents for stent-assisted coiling
    • 3.6.1. Procedure volumes forecast
    • 3.6.2. Market forecast
    • 3.6.3. Competitive analysis
  • 3.7. Flow diversion, flow disruption, and other embolic systems
    • 3.7.1. Procedure volumes forecast
    • 3.7.2. Market forecast
    • 3.7.3. Competitive analysis
  • 3.8. Bibliography
  • Exhibit 3-1: Embolization systems for treatment of cerebral aneurysms and AVMs, combined market forecast ($m), by region, 2017-22
  • Exhibit 3-2: Embolization systems for treatment of cerebral aneurysms and arteriovenous malformations, share of revenues by region, 2017
  • Exhibit 3-3: Cerebral aneurysm and AVM embolization systems, combined market forecast ($m), by product segment, 2017-22
  • Exhibit 3-4: Neuroendovascular embolization, procedure volumes forecast, by type of embolic system used, 2017-22
  • Exhibit 3-5: Neuroendovascular embolization procedures, combined procedure volumes forecast, 2017-22
  • Exhibit 3-6: Neuroendovascular embolization procedure volumes, share by country/region, 2017
  • Exhibit 3-7: Cerebral aneurysm and AVM embolization system sales, share by supplier, 2017
  • Exhibit 3-8: Embolic coiling, procedure volumes forecast, by region, 2017-22
  • Exhibit 3-9: Embolic coiling procedure volumes, share by country/region, 2017
  • Exhibit 3-10: Neuroendovascular coiling systems, market forecast ($m), 2017-22
  • Exhibit 3-11: Neuroendovascular coiling systems market, share by region, 2017
  • Exhibit 3-12: Neuroendovascular coiling systems market, share by supplier, 2017
  • Exhibit 3-13: Neuroendovascular liquid embolization, procedure volumes forecast, by region, 2017-22
  • Exhibit 3-14: Neuroendovascular liquid embolization procedures, share by region, 2017
  • Exhibit 3-15: Neuroendovascular liquid embolics, market forecast ($m), by region, 2017-22
  • Exhibit 3-16: Neuroendovascular liquid embolics market, share by region, 2017
  • Exhibit 3-17: Neuroendovascular liquid embolics market, share by supplier, 2017
  • Exhibit 3-18: Neuroendovascular stent-assisted coiling, procedure volumes forecast, share by region, 2017-22
  • Exhibit 3-19: Neuroendovascular stent assist coiling procedures, share by region, 2017
  • Exhibit 3-20: Coil-containment stents for intracranial applications, market forecast ($m), by region, 2017-22
  • Exhibit 3-21: Market for coil-containment stents for intracranial applications, share by country/region, 2017
  • Exhibit 3-22: Market for coil-containment stents for intracranial applications, share by supplier, 2017
  • Exhibit 3-23: Flow diversion and other embolization procedures, procedure volumes forecast, by country/region, 2017-22
  • Exhibit 3-24: Flow diversion and other embolization procedures, share by country/region, 2017
  • Exhibit 3-25: Flow diversion and other newly developed embolization systems, market forecast ($m), by country/region, 2017-22
  • Exhibit 3-26: Market for flow diversion and other embolization products, share by country/region, 2017
  • Exhibit 3-27: Market for flow diversion and other embolization products, share by supplier, 2017

APPENDIX: COMPANY LISTING